Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 04.02.2021.

#lifesciences
#news
#clinicalresearch
#pharma
#biotech
#healthcare
#medical
#pharmiweb
#clinicaltrials
#pharmaceuticals

Career And Jobs

@biospace shared
On Feb 3, 2021
@US_FDA Hit Record Drug and Biologic Approvals in 2020, Despite Ongoing Pandemic #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/zyMagLELld
Open
FDA Hit Record Drug and Biologic Approvals in 2020, Despite Ongoing Pandemic

FDA Hit Record Drug and Biologic Approvals in 2020, Despite Ongoing Pandemic

For the pharmaceutical industry, the lack of face-to-face meetings caused the U.S. Food and Drug Administration to implement regulatory workarounds to stay on top of drug and biologics ...

@BiotechWorld shared
On Feb 3, 2021
Abingworth raises $465M fund, steps up interest in CNS diseases https://t.co/1HmGaJVl7t https://t.co/W1k4dDoOJi
Open
Abingworth raises $465M fund, steps up interest in CNS diseases

Abingworth raises $465M fund, steps up interest in CNS diseases

Abingworth has raised a $465 million life sciences fund, positioning it to build on earlier investments in biotechs including Alnylam and CRISPR Therapeutics. The transatlantic fund will ...

@SynBioBeta shared
On Feb 3, 2021
Joint Team from MIT and @synlogic_tx Named a Biotechnology Grand Challenge Winner by @AFResearchLab. The goal of this work is to produce a live bacterial therapeutic that would improve pilot performance and decision-making https://t.co/ldZq6fLowl
Open
Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory

Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory

– Synlogic to provide bioprocess and manufacturing in joint effort to engineer novel investigational medicines to address battle fatigue – CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ — A ...

@pharminews shared
On Feb 2, 2021
MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer https://t.co/NeSXyDyx5w #news #pharma #clinicalresearch #biotech https://t.co/rffUPLCbLA
Open
MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer

CHICAGO--(BUSINESS WIRE)--#MAIA--MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on development of first-in-class oncology drugs, today announced a clinical ...

@SynBioBeta shared
On Feb 2, 2021
Meet @NFX's new fund, NfX Bio, which will be led by @omri_drory, @EmilyLeproust, @JamesCurrier and @GigiLevy 👏👩🏿‍🔬 They want the scientist to be the CEO, they're here to support scientists who want to learn how to be founders: https://t.co/aHdCt9n9uy
Open
New Synthetic Biology Venture Fund Puts ‘Scientist Founders’ First

New Synthetic Biology Venture Fund Puts ‘Scientist Founders’ First

Synthetic biology investment set a nearly $8 billion record in 2020. The trend of increased biotech venture capital continues in 2021 with the newly announced fund NFX Bio.

@pharminews shared
On Feb 3, 2021
Janssen to Present Robust Evidence for Solid Tumour Portfolio and Pipeline at 2021 ASCO GU https://t.co/C1RatGRXEI #news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/PVafKaHYYl
Open
Janssen to Present Robust Evidence for Solid Tumour Portfolio and Pipeline at 2021 ASCO GU

Janssen to Present Robust Evidence for Solid Tumour Portfolio and Pipeline at 2021 ASCO GU

Multiple data presentations to show long-term benefit and consistency of ERLEADA® (apalutamide)▼ in advanced prostate cancer; oral presentations to highlight Phase 3 ACIS, TITAN and SPARTAN ...

@pharminews shared
On Feb 1, 2021
Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality https://t.co/UUyquVyN9g #news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/X891h9vn0c
Open
Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality

Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality

The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in the pursuit of bioreactor process ...

@Pharmafocus shared
On Jan 29, 2021
Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial https://t.co/L8D8PN1f6j https://t.co/1M1E5OC33X
Open
Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial

Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial

Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.

Read more: Career And Jobs
weekly 04.02.2021
View archives
Back to home